Man, Howie's word wrangling sure did it's magic.His 6 months was...

Man, Howie's word wrangling sure did it's magic.

His 6 months was 6 month delay on revenue generation.

The review process takes 6 months from when the updated instructions are submitted to / accepted by the FDA.

So we are looking at the end January + 6 months to approval IF the resubmission is done before the end of January

This puts us at the end of July 2024 before the sales team can start working.

Howie also said we didn't originally expect revenue generation until Feb 2024, giving the sales team a month to earn their first sale. So using this, that puts us at end of August for revenue generation.

3rd quarter revenue won't be reported until after the end of the 3rd quarter. So figures will come out after 30 sept 2024. Hopefully sometime mid to late October 2024.

and this is all with the assumption of 0 delays in all of the resubmission steps plus sales force and reporting.

So from today, we should expect just over 12 months before seeing any sales figures.

This is how corporate speak makes 12+ months = 6 months in a presentation.

anyway, hope this helps clear up for some people.